ADVERTISEMENT

Kerri Fitzgerald

Pirfenidone Reduces Disease Progression in Patients with IPF

06/19/2014

Kerri Fitzgerald ;

Two previous phase 3 trials have found that pirfenidone reduced disease progression in patients with idiopathic pulmonary fibrosis (IPF), as measured by the decline in forced vital capacity (FVC) or vital capacity. However, another phase 3...

Two previous phase 3 trials have found that pirfenidone reduced disease progression in patients with idiopathic pulmonary fibrosis (IPF), as measured by the decline in forced vital capacity (FVC) or vital capacity. However, another phase 3...

Two previous phase 3 trials have...

06/19/2014

First Report Managed Care

Conference Insider

Using Data to Improve Clinical and Financial Outcomes

01/20/2015

Kerri Fitzgerald ;

With the growing implementation of electronic health records, patient data collection and integration has come to the forefront of healthcare management.

With the growing implementation of electronic health records, patient data collection and integration has come to the forefront of healthcare management.

With the growing implementation...

01/20/2015

First Report Managed Care

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

Derm Week

November 13 ⁠–⁠ November 16

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

See Full Calendar

Advertisement

Advertisement